-
Story /Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
-
Story /A diminutive protein prompts a closer look at DNA dark matter.
-
Featured News /
European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.
-
Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Story /Novartis is taming nuclear power and putting it to use to treat advanced cancer.
-
Story /Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
-
Featured News /
-
Featured News /
Learn how we are shifting from making the patient fit the treatment to making the treatment fit the patient.
-
Featured News /
A recent summit explored how technological advances could impact patient care.
-
Featured News /
The Novartis Foundation is launching a blood pressure management program in Vietnam as part of its larger effort to combat the rise of chronic diseases in urban areas of developing countries.